Zhang B - Search Results

1

Acidic tumor microenvironment-sensitive liposomes enhance colorectal cancer therapy by acting on both tumor cells and cancer-associated fibroblasts.

Li C, Li Z, Gong X, Liu J, Zheng T, Wang F, Wu J, Zhang B. Li C, et al. Among authors: zhang b. Nanoscale. 2021 Jun 17;13(23):10509-10525. doi: 10.1039/d1nr01506k. Nanoscale. 2021. PMID: 34096957

2

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.

Jiang H, Li ZP, Tian GX, Pan RY, Xu CM, Zhang B, Wu JL. Jiang H, et al. Among authors: zhang b. Int J Nanomedicine. 2019 Mar 8;14:1789-1804. doi: 10.2147/IJN.S188971. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30880980 Free PMC article.

3

Therapeutic drugs and drug delivery systems targeting stromal cells for cancer therapy: a review.

Li Z, Zheng Z, Li C, Li Z, Wu J, Zhang B. Li Z, et al. Among authors: zhang b. J Drug Target. 2020 Aug-Sep;28(7-8):714-726. doi: 10.1080/1061186X.2020.1744157. Epub 2020 Mar 25. J Drug Target. 2020. PMID: 32183540 Review.

4

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy.

Li Z, Liu C, Li C, Wang F, Liu J, Zheng Z, Wu J, Zhang B. Li Z, et al. Among authors: zhang b. J Nanobiotechnology. 2021 Dec 14;19(1):421. doi: 10.1186/s12951-021-01172-0. J Nanobiotechnology. 2021. PMID: 34906155 Free PMC article.

5

Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Zhao R, Liu J, Li Z, Zhang W, Wang F, Zhang B. Zhao R, et al. Among authors: zhang b, zhang w. Pharmaceutics. 2022 Jul 25;14(8):1541. doi: 10.3390/pharmaceutics14081541. Pharmaceutics. 2022. PMID: 35893797 Free PMC article. Review.

6

Bortezomib-loaded mixed micelles realize a "three-in-one" effect for enhanced breast cancer treatment.

Liu J, Xu X, Li Y, Xu J, Zhao R, Liu S, Wu J, Zhang L, Zhang B. Liu J, et al. Among authors: zhang l, zhang b. Biomater Sci. 2023 Jul 12;11(14):4890-4906. doi: 10.1039/d3bm00254c. Biomater Sci. 2023. PMID: 37306225

7

[Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].

Zhang Z, Wang Z, Liu X, Shi M, Chen G, Zhang B, Li Z, Song L. Zhang Z, et al. Among authors: zhang b. Zhongguo Fei Ai Za Zhi. 2012 Dec;15(12):720-4. doi: 10.3779/j.issn.1009-3419.2012.12.05. Zhongguo Fei Ai Za Zhi. 2012. PMID: 23249717 Free PMC article. Chinese.

8

Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1.

Li Q, Yang W, Zhang Q, Zhang D, Deng J, Chen B, Li P, Zhang H, Jiang Y, Li Y, Zhang B, Lin N. Li Q, et al. Among authors: zhang b, zhang q, zhang d, zhang h. Cancer Cell Int. 2024 Sep 13;24(1):315. doi: 10.1186/s12935-024-03489-w. Cancer Cell Int. 2024. PMID: 39272147 Free PMC article.

9

GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.

Wang Q, Ren H, Xu Y, Jiang J, Wudu M, Liu Z, Su H, Jiang X, Zhang Y, Zhang B, Qiu X. Wang Q, et al. Among authors: zhang b, zhang y. Exp Cell Res. 2020 Feb 15;387(2):111806. doi: 10.1016/j.yexcr.2019.111806. Epub 2019 Dec 28. Exp Cell Res. 2020. PMID: 31891681

10

Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.

Deng X, Ma Q, Zhang B, Jiang H, Zhang Z, Wang Y. Deng X, et al. Among authors: zhang b, zhang z. Exp Cell Res. 2013 Oct 15;319(17):2545-53. doi: 10.1016/j.yexcr.2013.05.016. Epub 2013 Jun 18. Exp Cell Res. 2013. PMID: 23791940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,002 results

Search Page

Filters